Marantz Jing L. 4
4 · Scholar Rock Holding Corp · Filed Feb 19, 2026
Research Summary
AI-generated summary of this filing
Scholar Rock (SRRK) CMO Jing L. Marantz Sells Shares
What Happened Jing L. Marantz, Chief Medical Officer of Scholar Rock Holding Corp (SRRK), sold 4,157 shares on February 17, 2026 at $46.53 per share, generating proceeds of $193,418. The filing indicates this sale was a broker-facilitated "sell to cover" required to satisfy tax withholding on RSUs that vested on February 15, 2026, and not a discretionary open-market trade.
Key Details
- Transaction date and price: Feb 17, 2026 — 4,157 shares sold at $46.53 each (total ~$193,418).
- Reason: Sale mandated to cover tax withholding on RSU vesting (per footnote F1); executed via a brokerage firm designated by the issuer.
- Vesting info (per F1): Shares vested pursuant to RSU awards granted Feb 13, 2023 and Mar 10, 2025; RSUs vest annually over four years, subject to continued service.
- Holdings after transaction (per footnote F2): 29,388 shares of common stock and 96,624 RSUs.
- Filing: Form 4 filed Feb 19, 2026, two days after the transaction — no late filing indicated.
Context A "sell to cover" is a routine, non-discretionary transaction where an employer-directed sale covers tax withholding on vested equity and does not necessarily signal the insider's view on the company's prospects. For retail investors, outright purchases or discretionary sales typically carry more informational weight than mandatory tax-withholding sales.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-02-17$46.53/sh−4,157$193,418→ 126,012 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on February 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. The shares vested pursuant to awards that were granted on February 13, 2023 and March 10, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date.
- [F2]Consists of 29,388 shares of common stock and 96,624 RSUs.